Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Feb 26, 2025, 8:34 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Ginkgo Bioworks reported disappointing quarterly results, leading to a significant drop in share price. Historically, poor earnings can trigger a negative pricing trend, as seen with other biotech stocks experiencing similar downturns.
AI summary
What happened, with direct paths to the underlying reporting
U.S. stock futures rose with Dow gaining around 100 points. Ginkgo Bioworks (DNA) shares fell 13% to $8.96 in pre-market trading. Ginkgo's quarterly results were weaker than expected, triggering a stock drop. CareDx Inc (CDNA) also experienced a significant drop of 18.1%. Weak performance in biotech affects investor sentiment towards related stocks.
U.S. stock futures rose with Dow gaining around 100 points.
Ginkgo Bioworks (DNA) shares fell 13% to $8.96 in pre-market trading.
Ginkgo's quarterly results were weaker than expected, triggering a stock drop.
CareDx Inc (CDNA) also experienced a significant drop of 18.1%.
Weak performance in biotech affects investor sentiment towards related stocks.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Ginkgo Bioworks faced a significant sell-off post its disappointing Q4 and full-year 2025 results, raising investor concerns about growth sustainability. The company may struggle…
Scorpion Capital labeled Ginkgo a 'colossal scam' over failed projects. Ginkgo's stock fell 12% after the report and has since lost 97% value. A shareholder lawsuit cited violatio…
Ginkgo Bioworks plans a reverse stock split of 1-for-20 to 1-for-40. Shareholders will vote on this plan on August 14, 2024. The split aims to prevent delisting from the NYSE due…
- Ginkgo Bioworks (DNA) announces layoffs affecting 35% of its workers, about 400 employees. - The layoffs are part of a restructuring plan to reduce labor costs by 25%. - Initial…